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Abstract
Two intramolecularly quenched fluorogenic peptides containing o-
aminobenzoyl (Abz) and ethylenediamine 2,4-dinitrophenyl (EDDnp)
groups at amino- and carboxyl-terminal amino acid residues, Abz-
DArg-Arg-Leu-EDDnp (Abz-DRRL-EDDnp) and Abz-DArg-Arg-Phe-
EDDnp (Abz-DRRF-EDDnp), were selectively hydrolyzed by neutral
endopeptidase (NEP, enkephalinase, neprilysin, EC 3.4.24.11) at the
Arg-Leu and Arg-Phe bonds, respectively. The kinetic parameters for
the NEP-catalyzed hydrolysis of Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp were Km = 2.8 µM, kcat = 5.3 min-1, kcat/Km = 2 min-1 µM-1 and
Km = 5.0 µM, kcat = 7.0 min-1, kcat/Km = 1.4 min-1 µM-1, respectively.
The high specificity of these substrates was demonstrated by their
resistance to hydrolysis by metalloproteases [thermolysin (EC 3.4.24.2),
angiotensin-converting enzyme (ACE; EC 3.4.24.15)], serineproteases
[trypsin (EC 3.4.21.4), α-chymotrypsin (EC 3.4.21.1)] and proteases
present in tissue homogenates from kidney, lung, brain and testis. The
blocked amino- and carboxyl-terminal amino acids protected these
substrates against the action of aminopeptidases, carboxypeptidases
and ACE. Furthermore, DR amino acids ensured total protection of
Abz-DRRL-EDDnp and Abz-DRRF-EDDnp against the action of ther-
molysin and trypsin. Leu-EDDnp and Phe-EDDnp were resistant to
hydrolysis by α-chymotrypsin. The high specifity of these substrates
suggests their use for specific NEP assays in crude enzyme prepara-
tions.
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Neutral endopeptidase (NEP, enkepha-
linase, neprilysin, EC 3.4.24.11) is a broadly
specific zinc metalloendopeptidase which
hydrolyzes internal peptide bonds on the
amino side of hydrophobic amino acid resi-
dues in P’1 position, with Leu or Phe being
the preferred amino acids. Shown to be widely
distributed in various tissues, NEP is in-
volved in the regulation and metabolism of a
variety of biologically active peptides such
as substance P, enkephalins, atrial natriuret-
ic factor, bradykinin, gastrin, neurotensin,
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and the chemotactic peptide (1,2).
Several synthetic substrates have been
developed to measure NEP activity, such as
radiolabeled peptides ([3H]Leu-enkephalin,
D-[3H]Ala2-Leu-enkephalin) (3,4), chro-
mogenic peptides (glutaryl-Ala-Ala-Phe-
2NA, benzyl-Gly-Arg-Arg-Leu-2NA) (5,6)
and fluorogenic peptides (dansyl-D-Ala-Gly-
Phe(pNO2)-Gly, dansyl-Gly-Phe(pNO2)-
ßAla) (7,8).
Although the specificity of all these sub-
strates for NEP is partial, and frequently the
use of other protease inhibitors is required
during incubation with NEP, they are used to
monitor NEP purification, to determine its
activity in different tissues under physiologi-
cal and pathological conditions, as well as to
compare the kinetic parameters of different
forms of recombinant NEP produced by site-
directed mutagenesis, to develop synthetic
inhibitors which have been employed to study
the physiological functions of NEP, and for
clinical use through the increased level of
endogenous peptides that are substrates for
the enzyme (1,2,9).
Recently, we described a new intramo-
lecularly quenched fluorogenic substrate for
NEP related to Leu-enkephalin, containing
o-aminobenzoyl (Abz) and ethylenediamine
2,4-dinitrophenyl (EDDnp) groups at amino-
and carboxyl-terminal amino acid residues,
Abz-GGDFLRRV-EDDnp (10,11). This sub-
strate presents at least one important advan-
tage in relation to other previously described
fluorogenic substrates for NEP: its kcat/Km =
40 min-1 µM-1 is 20 times higher than that of
dansyl-D-Ala-Gly-Phe(pNO2)-Gly (7) and
dansyl-Gly-Phe(pNO2)-ßAla (8). Although
Abz-GGDFLRRV-EDDnp also presents good
specificity for NEP, since it is resistant to
other metalloendopeptidases such as angio-
tensin-converting enzyme (ACE; EC
3.4.24.15) and thermolysin (EC 3.4.24.2), it
is partially susceptible to degradation by
trypsin-like enzymes which may cleave the
R-R bond.
In the present study, we document two
new intramolecularly quenched fluorogenic
substrates for NEP, Abz-DRRL-EDDnp and
Abz-DRRF-EDDnp, which were totally re-
sistant to the action of other metalloproteases
(ACE, thermolysin), serineproteases (tryp-
sin, EC 3.4.21.4 and chymotrypsin, EC
3.4.21.1) and proteases present in homoge-
nates of several tissues.
The internally quenched fluorogenic pep-
tides Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp were synthesized by the solution
method (12,13). A recombinant soluble form
of NEP (rNEP) was expressed using a
baculovirus/insect-cell system and purified
by immunoaffinity as previously described
(14,15).
A crude membrane preparation was ob-
tained from rat tissues as described earlier
(10). Briefly, rat tissues were homogenized
in 8 volumes (w/v) of 50 mM Tris-HCl buffer,
pH 7.5, using a Potter homogenizer, the ho-
mogenate was centrifuged for 10 min at
1,000 g and the pellet was discarded, the
supernatant was centrifuged at 80,000 g for
60 min, the pellet was washed four times by
resuspension in the same buffer used for
homogenization and centrifuged under the
conditions described above, and the result-
ing pellet, resuspended in 50 mM Tris-HCl
buffer, pH 7.5 (1/8; w/v), was used as the
enzyme source. Protein was measured by the
method of Bradford (16). Angiotensin-con-
verting enzyme was purified from guinea pig
serum (17).
The synthetic substrates (Abz-DRRL-
EDDnp and Abz-DRRF-EDDnp) and their
enzymatic products were characterized by
high-performance liquid chromatography
(HPLC) as follows: the substrate (20 nmol)
was incubated with purified rNEP (600 ng)
or crude enzyme fractions (1-10 µl) in a final
volume of 100 µl 50 mM Tris-HCl buffer,
pH 7.5, at 37oC for 60 min. In inhibition
assays, the enzyme was preincubated with 1
µM phosphoramidon for 20 min before in-
cubation with substrates. The reaction was
stopped by heating for 5 min at 100oC. After
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centrifugation at 10,000 g for 10 min, the
supernatant fraction was injected into an
HPLC column (Nucleosil 5 µm C18, 145 x
4.5 mm) and eluted with a 20-40% gradient
of acetonitrile containing 0.05% trifluoracetic
acid for a period of 50 min, at a flow rate of
1 ml/min. The intact substrate and products,
detected by both UV absorbance (220 nm)
and fluorescence (λem = 420 nm, λex = 320
nm) with the detectors arranged in series,
were collected to identify the cleavage site
by amino acid analysis (18).
The enzyme assays were monitored by
measuring the fluorescence at λem = 420 nm
and λex = 320 nm with a Shimadzu model F
2000 spectrofluorimeter. The 0.5 x 1 cm
path-length cuvette containing 500 µl of the
mixture of 50 mM Tris-HCl buffer, pH 7.5,
and Abz-DRRL-EDDnp (10 µM) was placed
in the thermostat cell compartment at 37oC
for 5 min until temperature equilibrium of
the solution was attained. When kidney ho-
mogenate (10 µl) was used, the fluorescence
course was recorded continuously for 40
min. For the inhibition assay, the enzyme
was preincubated with the inhibitor for 20
min at 37oC before incubation with sub-
strates. The same conditions were used for
thermolysin, chymotrypsin, trypsin and ACE
at concentrations of 0.15 µg/ml, 8 µg/ml, 15
µg/ml and 10 µg/ml, respectively.
The kinetic parameters for the hydrolysis
of Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp by rNEP were determined from a
double-reciprocal Lineweaver-Burk plot.
rNEP has an apparent MW of 87,000 (14) and
this value was used for the calculation of kcat.
The substrate Abz-DRRL-EDDnp pre-
sented the lowest Km value (2.8 µM) similar
to 3 µM obtained for the longer substrate
derived from Leu-enkephalin, Abz-GG
DFLRRV-EDDnp (10,11) (Table 1A). Fur-
thermore, although Abz-DRRL-EDDnp pre-
sented a lower kcat/Km value (2 min-1 µM-1)
than Abz-GGDFLRRV-EDDnp (42 min-1 µM-1)
(10,11), this value was higher than those of
all the short synthetic peptides presented in
Table 1A.
All the substrates presented in Table 1A
contain a hydrophobic residue at the P’1
position (Leu, Phe or Val), an essential con-
dition for NEP activity (1,19). Thus, the
excellent kinetic parameters of Abz-DRRL-
EDDnp and Abz-GGDFLRRV-EDDnp may
be also explained by interactions of their
groups with subsites on the surface of NEP.
In these substrates, the presence of EDDnp,
a hydrophobic group at position P’2, may
suggest a strong interaction with an S’2 subsite
of NEP.
Table 1B shows the activity of NEP,
other metalloendopeptidases (ACE and ther-
molysin) and serineproteases (trypsin and α-
chymotrypsin) toward Abz-DRRL-EDDnp,
Abz-DRRF-EDDnp and several other syn-
thetic peptides. In contrast to all the other
substrates, only Abz-DRRL-EDDnp and Abz-
DRRF-EDDnp were totally resistant to the
action of ACE, thermolysin, trypsin and α-
chymotrypsin. Furthermore, the activity to-
ward Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp present in kidney homogenate (Fig-
ure 1) and in tissue homogenates of lung,
brain and testis (data not shown) was totally
inhibited by 1 µM phosphoramidon (a highly
specific NEP inhibitor), showing also the
high resistance of these substrates to other
tissue proteases.
It has been previously demonstrated that
the Abz and EDDnp groups at amino- and
carboxy-terminal amino acid residues pro-
tect peptides against the action of aminopep-
tidases, carboxypeptidases and ACE (10,11).
However, these groups do not protect pep-
tides against the action of thermolysin or
trypsin, since the substrate Abz-RRL-
EDDnp, containing R at position P’2, was
hydrolyzed by these enzymes (data not
shown). Thus, the presence of DR at position
P’2 ensured a total protection of Abz-DRRL-
EDDnp and Abz-DRRF-EDDnp against ther-
molysin and trypsin. Finally, it may be sug-
gested that EDDnp ensures a total protection
of the L-EDDnp and F-EDDnp bonds against
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the action of α-chymotrypsin, since no amino
acid is involved.
We have previously shown that the in-
tramolecularly quenched fluorogenic pep-
tide Abz-GGDFLRRV-EDDnp can be used
for a rapid, highly selective and sensitive
NEP assay (10,11). Indeed, since the cata-
lytic constants obtained with Abz-GG
DFLRRV-EDDnp are better than those ob-
tained with Abz-DRRL-EDDnp, Abz-DRRF-
EDDnp and other synthetic peptides shown
here, it is the best substrate for use in NEP
assays. As shown in Table 1B, although
resistant to hydrolysis by ACE, thermolysin
and α-chymotrypsin, Abz-GGDFLRRV-
EDDnp was hydrolyzed at the R-R bond by
trypsin, suggesting that it may also be sus-
ceptible to hydrolysis by trypsin-like en-
zymes present in some crude enzyme prepa-
rations. Taken together, these results show
that Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp are substrates more specific for NEP
than Abz-GGDFLRRV-EDDnp.
Finally, the results presented in this study
Table 1 - A, Comparison of the kinetic parameters for hydrolysis of Abz-DRRL-EDDnp and Abz-DRRF-EDDnp by
NEP with those of Leu-enkephalin and other synthetic substrates used in current NEP assays. aMean values ±
SEM of four independent determinations. The arrows indicate the peptide bonds cleaved by NEP.
B, Incubation of Abz-DRRL-EDDnp, Abz-DRRF-EDDnp, Abz-GGDFLRRV-EDDnp and other synthetic substrates
with NEP (0.5 µg/ml), ACE (10 µg/ml), thermolysin (0.15 µg/ml), trypsin (15 µg/ml), and chymotrypsin (8 µg/ml).
Reactions were carried out at pH 7.5 and 37oC. Concentration was 10 µM for substrates 1,2 and 3. nd, Not
determined.
A
Substrates Km (µM) kcat (min-1) kcat/Km (min-1 µM-1) References
(1) Abz-DR-R ↓ L-EDDnp 2.8 ± 1.5a 5.3 2 -
(2) Abz-DR-R ↓ F-EDDnp 5 ± 1.5a 7 1.4 -
(3) Abz-G-G-F-L-R-R ↓ V-EDDnp 17 ± 1.5a 736 43 10,11
(4) Abz-G-G-DF-L-R-R ↓ V-EDDnp 3 ± 2a 127 42 10,11
(5) Y-DA-G ↓ F-L 22 508 23 14
19 - - 20
49 - - 4
(6) Glutaryl-A-A ↓ F-2NA 590 592 1 5,6
(7) Benzyl-G-R-R ↓ L-2NA 180 240 1.3 5
(8) Dansyl-DA-G ↓ F-(pNO2)-G 45 59 1.3 7
(9) Dansyl-G ↓ F-(pNO2)-ßA 37 68 1.8 8
(10) Suc-A-A ↓ F-NH-Np 76 2.19 0.029 19
(11) Suc-A-A ↓ L-NH-Np 5.1 290 0.017 19
(12) Suc-P-A ↓ F-NH-Np 0.905 50 0.018 19
B
Substrates Neutral ACE Thermolysin Trypsin Chymotrypsin References
endopeptidase
(1) Abz-DR-R-L-EDDnp + - - - - -
(2) Abz-DR-R-F-EDDnp + - - - - -
(3) Abz-G-G-DF-L-R-R-V-EDDnp + - - + - 10,11
(4) Suc-A-A-F-NH-Np + nd + nd + 19
(5) Suc-A-A-L-NH-Np + nd + nd + 19
(6) Suc-P-A-F-NH-Np + nd + nd + 19
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Figure 1 - A, HPLC elution pro-
file of Abz-DRRL-EDDnp after
hydrolysis by rat kidney homog-
enate (AI) and inhibition of the
reaction by phosphoramidon
(AII). The substrate (20 nmol)
was incubated with 10 µl kidney
homogenate (180 µg/ml) for 60
min in 100 µl 50 mM Tris-HCl
buffer, pH 7.5, at 37oC, in the
presence or absence of 1 µM
phosphoramidon. The reaction
was stopped by heating the mix-
ture at 100oC for 5 min followed
by centrifugation at 10,000 g for
10 min. An aliquot of the super-
natant (100 µl) corresponding to
90% of the reaction mixture was
submitted to HPLC as described
in the text. B, Continuous fluo-
rescence recording (λem = 420
nm, λex = 320 nm) of the hy-
drolysis of Abz-DRRL-EDDnp (10
µM) by the enzymes presented
from top to bottom: kidney ho-
mogenate (10 µl) in the absence
or presence of 1 µM phosphor-
amidon, ACE (10 µg/ml), ther-
molysin (0.15 µg/ml), trypsin (15
µg/ml) and α-chymotrypsin (8
µg/ml). All incubations were per-
formed in a final volume of 500
µl 50 mM Tris-HCl buffer, pH
7.5, at 37oC.
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lead us to the following conclusions: i) the
previously described substrate Abz-
GGDFLRRV-EDDnp (10,11), which presents
the best kinetic parameters, is more suitable
than Abz-DRRL-EDDnp and Abz-DRRF-
EDDnp for NEP assays in purified enzyme
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